Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription


31.10.2022

1 Aliment Pharmacol Ther
1 Am J Gastroenterol
1 Clin Gastroenterol Hepatol
4 Dig Dis Sci
9 Gastroenterology
1 Inflamm Bowel Dis
2 J Crohns Colitis
2 J Gastroenterol
2 Lancet Gastroenterol Hepatol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. STRAATMIJER T, van Schaik FDM, Bodelier AGL, Visschedijk M, et al
    Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry.
    Aliment Pharmacol Ther. 2022 Oct 25. doi: 10.1111/apt.17248.
    PubMed         Abstract available


    Am J Gastroenterol

  2. BERNSTEIN CN, Fisk JD, Walld R, Bolton JM, et al
    Use of Benzodiazepines and Z-Drugs in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2022 Oct 27. pii: 00000434-990000000-00474.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  3. BALASUBRAMANIAM M, Nandi N, Aswani-Omprakash T, Sebastian S, et al
    Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia.
    Clin Gastroenterol Hepatol. 2022;20:2421-2426.
    PubMed        


    Dig Dis Sci

  4. SHERRILL GC, Esckilsen S, Hudson J, Kochar B, et al
    Relationship Between Stages of Ileal Pouch-Anal Anastomosis, Timing of Restoration of Fecal Continuity, and Pouchitis.
    Dig Dis Sci. 2022;67:5220-5226.
    PubMed         Abstract available

  5. HERMAN HS, Rosenthaler MP, Elhassan N, Weinberg JM, et al
    COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Diseases at a Diverse Safety Net Hospital.
    Dig Dis Sci. 2022;67:5029-5033.
    PubMed         Abstract available

  6. KOCHAR BD, Cheng D, Cai T, Ananthakrishnan AN, et al
    Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:5206-5212.
    PubMed         Abstract available

  7. SIEBER A, Aberra FN, Bonhomme B, McKeever L, et al
    Influence of Corticosteroid Use on Short- and Long-Term Outcomes of Biologic Therapy for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:5168-5176.
    PubMed         Abstract available


    Gastroenterology

  8. WU N, Hong SK, Huang WF
    Multiple Strictures of Small Intestine: Is It Crohn's Disease?
    Gastroenterology. 2022;163:e1-e2.
    PubMed        

  9. LEIBOVITZH H, Lee SH, Xue M, Raygoza Garay JA, et al
    Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
    Gastroenterology. 2022;163:1364-1376.
    PubMed         Abstract available

  10. FOCHT G, Cytter-Kuint R, Greer MC, Pratt LT, et al
    Development, Validation, and Evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index From the ImageKids Study.
    Gastroenterology. 2022;163:1306-1320.
    PubMed         Abstract available

  11. KHANNA R
    Risankizumab for Induction and Maintenance of Remission in Crohn's Disease.
    Gastroenterology. 2022;163:1470-1471.
    PubMed        

  12. DOLINGER MT, Dubinsky MC
    The Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index: A Step Forward for Transmural Pediatric Crohn's Disease Monitoring and Healing.
    Gastroenterology. 2022;163:1166-1167.
    PubMed        

  13. GREEN PHR, Paski S, Ko CW, Rubio-Tapia A, et al
    AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
    Gastroenterology. 2022;163:1461-1469.
    PubMed         Abstract available

  14. BALASUBRAMANIAM M, Nandi N, Aswani-Omprakash T, Sebastian S, et al
    Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia.
    Gastroenterology. 2022;163:1145-1150.
    PubMed        

  15. BOURGONJE AR
    Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
    Gastroenterology. 2022 Oct 21. pii: S0016-5085(22)01194.
    PubMed        

  16. FORSS A, Ludvigsson JF, Olen O
    Letter to the Editor regarding "The Rising Burden of Inflammatory Bowel Disease in Denmark over Two Decades: A Nationwide Cohort Study" by Agrawal et al.
    Gastroenterology. 2022 Oct 21. pii: S0016-5085(22)01193.
    PubMed        


    Inflamm Bowel Dis

  17. GOLD SL, Manning L, Kohler D, Ungaro R, et al
    Micronutrients and Their Role in Inflammatory Bowel Disease: Function, Assessment, Supplementation, and Impact on Clinical Outcomes Including Muscle Health.
    Inflamm Bowel Dis. 2022 Oct 26. pii: 6774890. doi: 10.1093.
    PubMed        


    J Crohns Colitis

  18. BARRAU M, Duprat M, Veyrard P, Tournier Q, et al
    A Systematic Review on the interest of Drug Tolerant assay in the monitoring of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Oct 27. pii: 6775962. doi: 10.1093.
    PubMed         Abstract available

  19. LE HD, Pflaum T, Labrenz J, Sari S, et al
    Interobserver reliability of the Nancy index for ulcerative colitis: An assessment of the practicability and ease of use in a single-centre real-world setting.
    J Crohns Colitis. 2022 Oct 25. pii: 6773056. doi: 10.1093.
    PubMed         Abstract available


    J Gastroenterol

  20. YAMAWAKA T, Kitamoto H, Nojima M, Kazama T, et al
    The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection.
    J Gastroenterol. 2022 Oct 26. pii: 10.1007/s00535-022-01931.
    PubMed         Abstract available

  21. MATSUOKA K, Fujii T, Okamoto R, Yamada A, et al
    Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD).
    J Gastroenterol. 2022;57:867-878.
    PubMed         Abstract available


    Lancet Gastroenterol Hepatol

  22. ATIA O, Shavit-Brunschwig Z, Mould DR, Stein R, et al
    Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study.
    Lancet Gastroenterol Hepatol. 2022 Oct 25. pii: S2468-1253(22)00307.
    PubMed         Abstract available

  23. QUAN J, Ma C, Panaccione R, Hracs L, et al
    Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2022 Oct 25. pii: S2468-1253(22)00340.
    PubMed        


    PLoS One

  24. DOTTI I, Mayorgas A, Salas A
    Generation of human colon organoids from healthy and inflammatory bowel disease mucosa.
    PLoS One. 2022;17:e0276195.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: